ClinVar Miner

Submissions for variant NM_000350.3(ABCA4):c.2461T>A (p.Trp821Arg)

gnomAD frequency: 0.00001  dbSNP: rs61749433
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Blueprint Genetics RCV001075705 SCV001241333 pathogenic Retinal dystrophy 2019-04-24 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000085480 SCV001380148 pathogenic not provided 2025-01-15 criteria provided, single submitter clinical testing This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 821 of the ABCA4 protein (p.Trp821Arg). This variant is present in population databases (rs61749433, gnomAD 0.002%). This missense change has been observed in individual(s) with Stargardt disease or cone-rod dystrophy (PMID: 9973280, 22247458, 26593885; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 99136). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.
GeneDx RCV000085480 SCV002504015 pathogenic not provided 2021-11-10 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 11702214, 9973280, 11328725, 18652558, 24677105, 11527935, 25301883, 19265867, 11726554, 28430335, 29925512, 33375396, 26593885, 28365912, 25283059, 25474345, 29178665, 20128570, 22247458)
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV004586548 SCV005075864 pathogenic Retinitis pigmentosa 2024-04-02 criteria provided, single submitter clinical testing Variant summary: ABCA4 c.2461T>A (p.Trp821Arg) results in a non-conservative amino acid change located in the ABC-2 type transporter, transmembrane domain (IPR013525) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251166 control chromosomes. c.2461T>A has been reported in the literature in multiple individuals affected with Stargardt disease (example, Cideciyan_2012, Duncker_2015, Fumagalli_2001, Verdina_2018, Zaneveld_2015). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22247458, 25283059, 11702214, 28365912, 25474345). ClinVar contains an entry for this variant (Variation ID: 99136). Based on the evidence outlined above, the variant was classified as pathogenic.
Fulgent Genetics, Fulgent Genetics RCV005025148 SCV005659555 pathogenic Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 2024-04-03 criteria provided, single submitter clinical testing
Retina International RCV000085480 SCV000117617 not provided not provided no assertion provided not provided
PreventionGenetics, part of Exact Sciences RCV004732665 SCV005360602 pathogenic ABCA4-related disorder 2024-08-28 no assertion criteria provided clinical testing The ABCA4 c.2461T>A variant is predicted to result in the amino acid substitution p.Trp821Arg. This variant has been reported to be causative for Stargardt disease (STGD) and ABCA4-related retinopathy (Shroyer et al. 1999. PubMed ID: 10396622; Lewis et al. 1999. PubMed ID: 9973280; Shroyer et al. 2001. PubMed ID: 11726554; Webster et al. 2001. PubMed ID: 11328725; Bianco et al 2023. PubMed ID: 37498587). This variant is reported in 0.0023% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant has been classified as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/99136). Given the evidence, we too interpret c.2461T>A (p.Trp821Arg) as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.